Drug intelligence / Profile preview

AGS-8M4 + carboplatin + gemcitabine

Development stage: Unknown
Lead developer: Astellas Pharma
Modality: Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
Administration: Intravenous

Overview

AGS-8M4 + carboplatin + gemcitabine is an investigational combination regimen, with AGS-8M4 (also referred to as ASP6183) being a human monoclonal antibody, typically considered for use with established chemotherapy drugs carboplatin and gemcitabine. AGS-8M4 is an anti-cancer antibody studied for safety, pharmacokinetics, immunogenicity, and anti-tumor activity, while carboplatin (a platinum analog) and gemcitabine (a nucleoside analog) are used together to inhibit DNA synthesis and cell division in cancer cells. The combination is used or explored as a treatment for several cancers, including advanced solid tumors and ovarian cancer.

Brand names: GemCarbo
Other names: gemcitabine and carboplatingemcitabine plus carboplatin

Targets

RNR (Ribonucleotide reductase)DNA

Beyond the preview

Go deeper on AGS-8M4 + carboplatin + gemcitabine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGS-8M4 + carboplatin + gemcitabine.

Explore the full profile